Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Müschen

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|September 23, 2000
Defining CD95 as a tumor suppressor geneM Müschen, U Warskulat, M W Beckmann
Biological Chemistry|November 1, 1996
Induction of mouse embryonal carcinoma cell differentiation and activation of the retinoic acid receptor beta 2 promoter by 1,25-dihydroxyvitamin D3M Müschen, H Sies, W A Schulz
Hepatology (Baltimore, Md.)|January 13, 1998
Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cellsM Müschen, U Warskulat, P Douillard, et al.
Biological Chemistry|October 29, 1998
Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by interferon gamma and all-trans retinoic acidM Müschen, U Warskulat, B Schmidt, et al.
Oncogene|April 26, 2006
SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cellsM Sprangers, N Feldhahn, S Liedtke, et al.
The Journal of Experimental Medicine|December 20, 2000
Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reactionM Müschen, D Re, B Jungnickel, et al.
Immunology|January 29, 2000
CD95 ligand expression as a mechanism of immune escape in breast cancerM Müschen, C Moers, U Warskulat, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 20, 2001
Molecular single-cell analysis of Hodgkin- and Reed-Sternberg cells harboring unmutated immunoglobulin variable region genesM Müschen, R Küppers, T Spieker, et al.
Blood|February 7, 2001
Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusionsR Küppers, A Bräuninger, M Müschen, et al.
Leukemia|January 30, 2010
Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemiaF Fei, S Stoddart, M Müschen, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Molecular Medicine (Berlin, Germany)|September 23, 2000
Defining CD95 as a tumor suppressor geneM Müschen, U Warskulat, M W Beckmann
Biological Chemistry|November 1, 1996
Induction of mouse embryonal carcinoma cell differentiation and activation of the retinoic acid receptor beta 2 promoter by 1,25-dihydroxyvitamin D3M Müschen, H Sies, W A Schulz
Hepatology (Baltimore, Md.)|January 13, 1998
Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cellsM Müschen, U Warskulat, P Douillard, et al.
Biological Chemistry|October 29, 1998
Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by interferon gamma and all-trans retinoic acidM Müschen, U Warskulat, B Schmidt, et al.
Oncogene|April 26, 2006
SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cellsM Sprangers, N Feldhahn, S Liedtke, et al.
The Journal of Experimental Medicine|December 20, 2000
Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reactionM Müschen, D Re, B Jungnickel, et al.
Immunology|January 29, 2000
CD95 ligand expression as a mechanism of immune escape in breast cancerM Müschen, C Moers, U Warskulat, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 20, 2001
Molecular single-cell analysis of Hodgkin- and Reed-Sternberg cells harboring unmutated immunoglobulin variable region genesM Müschen, R Küppers, T Spieker, et al.
Blood|February 7, 2001
Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusionsR Küppers, A Bräuninger, M Müschen, et al.
Leukemia|January 30, 2010
Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemiaF Fei, S Stoddart, M Müschen, et al.
Pageof 3